Table 4.
Psoriasis severity | ||||
---|---|---|---|---|
Total (N=210) | Mild (N=157) | Moderate (N=42) | Severe (N=11) | |
SF-12v2: MCS | 42.92 ± 10.97 | 43.23 ± 11.22 | 42.45 ± 10.54 | 40.23 ± 9.26 |
SF-12v2: PCS | 51.41 ± 7.52 | 51.91 ± 6.86 | 51.15 ± 7.99 | 45.23 ± 11.78 |
Health state utility score | 0.654 ± 0.107 | 0.658 ± 0.104 | 0.653 ± 0.118 | 0.587 ± 0.076 |
Absenteeism% | 8.24 ± 19.27 | 9.38 ± 21.66 | 5.15 ± 10.01 | 4.75 ± 6.60 |
Presenteeism % | 25.03 ± 27.01 | 23.68 ± 26.52 | 25.88 ± 27.76 | 48.00 ± 26.83 |
Overall work impairment % | 28.80 ± 29.82 | 28.53 ± 30.64 | 28.32 ± 28.70 | 39.75 ± 17.63 |
Activityimpairment% | 28.95 ± 29.23 | 27.52 ± 27.61 | 32.62 ± 33.86 | 35.45 ± 33.57 |
Physician visits in the past 6 months | 6.69 ± 7.31 | 6.51 ± 6.76 | 7.40 ± 9.52 | 6.55 ± 5.47 |
Emergency room visits in the past 6 months | 0.79 ± 1.89 | 0.82 ± 2.05 | 0.74 ± 1.25 | 0.64 ± 1.50 |
Hospitalizations in the past 6 months | 0.25 ± 0.83 | 0.20 ± 0.70 | 0.43 ± 1.27 | 0.18 ± 0.40 |